(Q40337060)

English

Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?

scientific article published on April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? (English)

1 reference

Europe PubMed Central

19 September 2017

1 reference

based on heuristic

inferred from title

author name string

Henk Schonewille

1

1 reference

Europe PubMed Central

19 September 2017

Leo M G van de Watering

2

1 reference

Europe PubMed Central

19 September 2017

Anneke Brand

3

1 reference

Europe PubMed Central

19 September 2017

publication date

1 April 2006

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

46

1 reference

Europe PubMed Central

19 September 2017

4

1 reference

Europe PubMed Central

19 September 2017

630-635

1 reference

Europe PubMed Central

19 September 2017

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00764.X

21 January 2018

Red cell antibody problems in 1000 liver transplants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00764.X

21 January 2018

Autoantibody formation in the alloimmunized red blood cell recipient: clinical and laboratory implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00764.X

21 January 2018

RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00764.X

21 January 2018

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00764.X

21 January 2018

The incidence of development of irregular red cell antibodies in patients with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00764.X

21 January 2018

Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00764.X

21 January 2018

Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00764.X

21 January 2018

Loss of red cell alloantibodies over time

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00764.X

21 January 2018

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00764.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2006.00764.X

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40337060&oldid=2073310758"